Vireo Growth Inc. (VREOF)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-04-14

Key Insights

Vireo Growth Inc. has acquired The Hawthorne Gardening Company LLC, a subsidiary of The Scotts Miracle-Gro Company, for consideration of 213 million subordinate voting shares and warrants to purchase an additional 80 million shares.
The transaction provides Vireo with a significant boost in scale and capabilities in the hydroponics and gardening supplies market, which could accelerate its growth strategy.
The lock-up agreement and investor rights granted to the Seller Designee suggest a strategic partnership and alignment between Vireo and Scotts Miracle-Gro, which could benefit Vireo's long-term prospects.

Current Report Filed: 2026-04-06

Key Insights

Vireo Growth Inc. has completed the acquisition of Eaze Inc., a cannabis delivery company, through a merger transaction.
The merger agreement includes an earnout payment structure based on Eaze's future EBITDA performance, with the potential for additional Vireo shares to be issued to former Eaze shareholders.
As part of the transaction, Vireo has issued restricted stock units to certain Eaze employees to incentivize their continued employment and participation in the earnout payments.

Current Report Filed: 2026-03-25

Key Insights

Vireo Growth Inc. has acquired a majority stake in Medicine Man Technologies, Inc. (d/b/a Schwazze) through the purchase of its senior secured convertible notes and subsequent acquisition of its assets.
The acquisition was facilitated through a restructuring support agreement and a public auction, where Vireo Health of Colorado, LLC credit bid on the assets.
Vireo Growth Inc. now indirectly holds all of the issued and outstanding senior secured notes of Schwazze and has become the majority owner of the newly formed entity, Vireo Health of Rocky Mountain, LLC, which acquired Schwazze's assets.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.